Since lower expression of TET2 in mononuclear cells was detected in >86% of inflammation‐associated PAH cases (Potus et al., 2020), our findings suggest higher TET2 expression in PAH patients with scleroderma was somewhat perplexing and surprising to us. The gene discussed is TET2; the disease is scleroderma.